Citation: W. Oortwijn et al., Introduction: Mass screening, health technology assessment, and health policy in some European countries, INT J TE A, 17(3), 2001, pp. 269-274
Citation: Hd. Banta et W. Oortwijn, Health technology assessment and screening in the Netherlands - Case studies of mammography in breast cancer, PSA screening in prostate cancer, and ultrasound in normal pregnancy, INT J TE A, 17(3), 2001, pp. 369-379
Citation: D. Banta et W. Oortwijn, Conclusion - Health technology assessment and health care in the European Union, INT J TE A, 16(2), 2000, pp. 626-635
Authors:
Michiels, JJ
Freyburger, G
van der Graaf, F
Janssen, M
Oortwijn, W
van Beek, EJR
Citation: Jj. Michiels et al., Strategies for the safe and effective exclusion and diagnosis of deep veinthrombosis by the sequential use of clinical score, D-dimer testing, and compression ultrasonography, SEM THROMB, 26(6), 2000, pp. 657-667
Authors:
Oortwijn, W
Banta, D
Vondeling, H
Bouter, L
Citation: W. Oortwijn et al., Identification and priority setting for health technology assessment in The Netherlands: actors and activities, HEALTH POLI, 47(3), 1999, pp. 241-253